Syndrome News and Research

RSS

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Researchers create algorithm to protect surgical team members from COVID-19

Researchers from Stanford University's department of surgery have created an algorithm that aims to protect operating room team members who perform urgent and emergency operations from Coronavirus Disease 2019 (COVID-19) and rationally conserve the personal protective equipment they wear.

6 Apr 2020

Rush participates in clinical trial to test remdesivir as potential treatment for COVID-19

Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.

6 Apr 2020

Cranfield University helps design simple, low-cost ventilators for critically-ill COVID-19 patients

A simple, low-cost Bag Valve Mask (BVM) ventilator to help critically-ill COVID-19 patients has been rapidly designed by experts at Cranfield University (UK) and built in Georgia Tech (USA) in a matter of days.

6 Apr 2020

Should US schools close to thwart spread of COVID-19?

A new study used mathematical modeling to explore the benefits and risks of closing down the schools to prevent new cases and the possibility of absenteeism among health care workers because they need to care for their children at home and the ultimate effect of the step on reducing the risk of deaths due to COVID-19.

6 Apr 2020

Experimental drug APN01 prevents COVID-19 infection in the lab

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease.

6 Apr 2020

ATS releases new guidance to help clinicians manage COVID-19 patients

An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment.

6 Apr 2020

Researchers investigate link between air pollution and SARS-CoV-2 lethality in Italy

The world has been hit hard by coronavirus, and health services and authorities everywhere are struggling to reduce the spread, combat the disease and protect the population. Nevertheless, the pandemic will cost lives throughout the world.

6 Apr 2020

Analysis of causative protein genotype can help predict Alport syndrome severity

A Japanese research team has successfully developed a system to predict the severity of Alport syndrome, a serious hereditary kidney disease that occurs in about 1 out of 5,000 people in the US. Patients with Alport syndrome have abnormalities in the causative protein, type IV collagen, that often lead to chronic renal dysfunction requiring dialysis.

6 Apr 2020

Research suggests an avenue to treat, prevent genetic disorders in the womb

New research led by hearing scientists at Oregon Health & Science University suggests an avenue to treat and prevent intractable genetic disorders before birth.

6 Apr 2020

Asthma and coronavirus disease - COVID-19

On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.

5 Apr 2020

COVID-19 and renin-angiotensin system inhibitors

A new viewpoint article published in the journal JAMA Network in April 2020 deals with the use of a widely used category of cardiovascular medications in COVID-19 patients with hypertension, diabetes, and cardiovascular disease (CVD). These are the most common medical conditions that are found in COVID-19 patients and contribute disproportionately to mortality.

5 Apr 2020

Clinical trial to evaluate experimental COVID-19 drug is underway at Montefiore and Einstein

Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.

5 Apr 2020

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers.

5 Apr 2020

Researchers uncover mechanism by which gene mutations potentially give rise to kidney disease

Researchers from the Center for Precision Disease Modeling at the University of Maryland School of Medicine have uncovered a mechanism that appears to explain how certain genetic mutations give rise to a rare genetic kidney disorder called nephrotic syndrome.

5 Apr 2020

Antibody recovered from SARS survivor reveals potential vulnerability of new coronavirus

An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research.

3 Apr 2020

IRB Barcelona and Amazon join forces to develop computational tool in the fight against COVID-19

There are currently more than 10,000 scientific articles related to coronavirus infections. In fact, in recent weeks, research to combat COVID-19 has accelerated, and more than 4,000 new academic papers have been published on potential vaccines, therapies, and treatments.

3 Apr 2020

Researchers identify the most common characteristics of fatal COVID-19 cases

In a new study, researchers identified the most common characteristics of 85 COVID-19 patients who died in Wuhan, China in the early stages of the coronavirus pandemic.

3 Apr 2020

Magnetic stimulation of rectal nerves could help treat fecal incontinence

An ongoing study by the Medical College of Georgia on the role of magnetic stimulation of the rectal nerves to achieve better bowel control in patients with fecal incontinence is showing early promise. The technique is called translumbosacral neuromodulation therapy, or TNT.

2 Apr 2020

UIC participates in two clinical trials for COVID-19 treatments

The University of Illinois at Chicago is participating in two clinical trials for COVID-19 treatments.

2 Apr 2020

Syndrome News and Research

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Researchers create algorithm to protect surgical team members from COVID-19

Rush participates in clinical trial to test remdesivir as potential treatment for COVID-19

Cranfield University helps design simple, low-cost ventilators for critically-ill COVID-19 patients

Should US schools close to thwart spread of COVID-19?

Experimental drug APN01 prevents COVID-19 infection in the lab

ATS releases new guidance to help clinicians manage COVID-19 patients

Researchers investigate link between air pollution and SARS-CoV-2 lethality in Italy

Analysis of causative protein genotype can help predict Alport syndrome severity

Research suggests an avenue to treat, prevent genetic disorders in the womb

Asthma and coronavirus disease - COVID-19

COVID-19 and renin-angiotensin system inhibitors

Clinical trial to evaluate experimental COVID-19 drug is underway at Montefiore and Einstein

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

Researchers uncover mechanism by which gene mutations potentially give rise to kidney disease

Antibody recovered from SARS survivor reveals potential vulnerability of new coronavirus

IRB Barcelona and Amazon join forces to develop computational tool in the fight against COVID-19

Researchers identify the most common characteristics of fatal COVID-19 cases

Magnetic stimulation of rectal nerves could help treat fecal incontinence

UIC participates in two clinical trials for COVID-19 treatments

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News